Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Motianshi Touzi

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 4
Rounds per year 0.33
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Key employees Soon

Areas of investment

  • Medical Device
  • Dental
  • Manufacturing
  • Digital Media
  • Video

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Motianshi Touzi:
Typical Co-investors
Motianshi Touzi is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Motianshi Touzi:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
350 Capital Canada, Ontario, Toronto
Canadian Institutes of Health Research Canada, Ontario, Ottawa
CHG Coinvestment LLC -
Christopher Toomey Trust -
Co-Investor Switzerland, Zürich, Zurich
Coinsilium Group England, London, United Kingdom
Fifth Third Capital Cincinnati, Ohio, United States
First National Bank Of Omaha Nebraska, Omaha, United States
ForgeHealth Atlanta, Georgia, United States
Fujisan Magazine Service Japan, Kanagawa Prefecture, Kawasaki
Innovation Birmingham Campus Birmingham, England, United Kingdom
LEO Pharma New Jersey, Parsippany, United States
OpusPoint Partners New York, New York, United States
RSI Fund -
Sagamore Ventures Baltimore, Maryland, United States
SEED Venture Massachusetts, Taunton, United States
Shanxi Hongchuang -
SymphonyAlpha Ventures Madison, United States, Wisconsin
Tarena Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Medefa

Biopharma
Biotechnology
Medical
Wellness
04 Feb 2024 Zhuhai, Guangdong, China

Eighteeth

Dental
Manufacturing
Medical Device
$15M10 Jan 2023 Changzhou, Zhejiang, China

Eighteeth

Dental
Manufacturing
Medical Device
09 Jan 2023 Changzhou, Zhejiang, China

Digital Media
E-Commerce
Media and Entertainment
Video
$3M15 Mar 2016 Qingyang District, Sichuan, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Motianshi Touzi?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 3M
Rounds per year 0.33
Peak activity year 2023
Lead investments 0
Follow on index 0.20
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Medefa

Biopharma
Biotechnology
Medical
Wellness
04 Feb 2024 Zhuhai, Guangdong, China

Eighteeth

Dental
Manufacturing
Medical Device
$15M10 Jan 2023 Changzhou, Zhejiang, China

Eighteeth

Dental
Manufacturing
Medical Device
09 Jan 2023 Changzhou, Zhejiang, China

Digital Media
E-Commerce
Media and Entertainment
Video
$3M15 Mar 2016 Qingyang District, Sichuan, China
Crunchbase icon

Content report

The following text will be sent to our editors: